Acrigen Biosciences
David brings his experience translating new technologies into clinical therapies. Prior to founding Acrigen, David founded and was the CSO of Redwood Biosciences, an antibody-drug conjugate company that was acquired by Catalent Pharma Solutions where he then served as Global Head of R&D.
This person is not in any offices
Acrigen Biosciences
Acrigen Biosciences is an early-stage life science gene-editing company based in Berkeley, California. They are building a pipeline of therapies to treat genetic disorders using their proprietary precision gene-editing technology.